BrightSpring Health Services, Inc. BTSG
BTSG among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
BTSG and 9 peers, year by year
The 9 Health care companies closest to BTSG in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. | FY2025 | $12.9B | +28.2% | 11.8% | 2.3% | 1.5% | 3.1% | 10.2% | 1.34 |
| VTRS Viatris | FY2025 | $14.3B | −3.0% | 35.1% | −18.6% | −24.6% | 13.5% | −23.9% | 0.98 |
| LH Labcorp | FY2025 | $14.0B | +7.2% | 28.8% | 9.9% | 6.3% | 8.6% | 10.2% | 0.65 |
| DVA DaVita | FY2025 | $13.6B | +6.5% | - | 15.0% | 5.5% | 9.6% | n/m | n/m |
| HSIC Henry Schein | FY2025 | $13.2B | +4.0% | 31.1% | 5.0% | 3.0% | 4.3% | 12.3% | 0.96 |
| REGN Regeneron Pharmaceuticals | FY2025 | $14.3B | +1.0% | - | 24.9% | 31.4% | 28.4% | 14.4% | 0.06 |
| TEVA Teva Pharmaceutical Industries Ltd | FY2025 | $17.3B | +4.3% | 51.8% | 12.5% | 8.2% | 6.7% | 17.8% | 2.12 |
| IQV IQVIA | FY2025 | $16.3B | +5.9% | - | 13.4% | 8.3% | 12.6% | 20.9% | 2.42 |
| VRTX Vertex Pharmaceuticals | FY2025 | $12.0B | +8.9% | - | 34.8% | 32.9% | 26.6% | 21.2% | 0.00 |
| UHS Universal Health Services | FY2025 | $17.4B | +9.7% | - | 11.5% | 8.6% | 4.9% | 20.5% | 0.66 |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2022 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2022 to FY2025
Revenue as reported in the 10-K.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | $7.7B | $7.7B | $10.1B | $12.9B |
| VTRS Dec | $16.3B | $15.4B | $14.7B | $14.3B |
| LH Dec | $11.9B | $12.2B | $13.0B | $14.0B |
| DVA Dec | $11.6B | $12.1B | $12.8B | $13.6B |
| HSIC Dec | $12.6B | $12.3B | $12.7B | $13.2B |
| REGN Dec | $12.2B | $13.1B | $14.2B | $14.3B |
| TEVA Dec | $14.9B | $15.8B | $16.5B | $17.3B |
| IQV Dec | $14.4B | $15.0B | $15.4B | $16.3B |
| VRTX Dec | $8.9B | $9.9B | $11.0B | $12.0B |
| UHS Dec | $13.4B | $14.3B | $15.8B | $17.4B |
| Peer median | $12.6B | $13.1B | $14.2B | $14.3B |
Sales growth, FY2022 to FY2025
Revenue against the fiscal year before.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | - | +14.3% | +31.0% | +28.2% |
| VTRS Dec | −9.0% | −5.1% | −4.5% | −3.0% |
| LH Dec | −9.7% | +2.5% | +7.0% | +7.2% |
| DVA Dec | −0.1% | +4.6% | +5.6% | +6.5% |
| HSIC Dec | +2.0% | −2.4% | +2.7% | +4.0% |
| REGN Dec | −24.3% | +7.8% | +8.3% | +1.0% |
| TEVA Dec | −6.0% | +6.2% | +4.4% | +4.3% |
| IQV Dec | +3.9% | +4.0% | +2.8% | +5.9% |
| VRTX Dec | +17.9% | +10.5% | +11.7% | +8.9% |
| UHS Dec | +6.0% | +6.6% | +10.8% | +9.7% |
| Peer median | −0.1% | +4.6% | +5.6% | +5.9% |
Gross margin, FY2022 to FY2025
Gross profit / revenue.
Operating margin, FY2022 to FY2025
Operating income / revenue.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | 2.4% | 0.8% | 1.1% | 2.3% |
| VTRS Dec | 9.9% | 5.0% | 0.1% | −18.6% |
| LH Dec | 12.1% | 6.0% | 8.4% | 9.9% |
| DVA Dec | 11.5% | 13.2% | 16.3% | 15.0% |
| HSIC Dec | 5.9% | 5.0% | 4.9% | 5.0% |
| REGN Dec | 38.9% | 30.9% | 28.1% | 24.9% |
| TEVA Dec | −14.7% | 2.7% | −1.8% | 12.5% |
| IQV Dec | 12.5% | 13.2% | 14.3% | 13.4% |
| VRTX Dec | 48.2% | 38.8% | −2.1% | 34.8% |
| UHS Dec | 7.5% | 8.2% | 10.6% | 11.5% |
| Peer median | 11.5% | 8.2% | 8.4% | 12.5% |
Net margin, FY2022 to FY2025
Net income / revenue.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | −0.7% | −2.0% | −0.2% | 1.5% |
| VTRS Dec | 12.8% | 0.4% | −4.3% | −24.6% |
| LH Dec | 10.8% | 3.4% | 5.7% | 6.3% |
| DVA Dec | 4.8% | 5.7% | 7.3% | 5.5% |
| HSIC Dec | 4.3% | 3.4% | 3.1% | 3.0% |
| REGN Dec | 35.6% | 30.1% | 31.1% | 31.4% |
| TEVA Dec | −16.4% | −3.5% | −9.9% | 8.2% |
| IQV Dec | 7.6% | 9.1% | 8.9% | 8.3% |
| VRTX Dec | 37.2% | 36.7% | −4.9% | 32.9% |
| UHS Dec | 5.0% | 5.0% | 7.2% | 8.6% |
| Peer median | 7.6% | 5.0% | 5.7% | 8.2% |
Free cash flow, FY2022 to FY2025
Cash from operations minus capital spending.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | −$74.8M | $137.3M | −$57.1M | $394.7M |
| VTRS Dec | $2.6B | $2.5B | $2.0B | $1.9B |
| LH Dec | $1.5B | $874.1M | $1.1B | $1.2B |
| DVA Dec | $961.1M | $1.5B | $1.5B | $1.3B |
| HSIC Dec | $506.0M | $353.0M | $700.0M | $573.0M |
| REGN Dec | $4.4B | $3.9B | $3.7B | $4.1B |
| TEVA Dec | $1.0B | $842.0M | $749.0M | $1.1B |
| IQV Dec | $1.6B | $1.5B | $2.1B | $2.1B |
| VRTX Dec | $3.9B | $3.3B | −$790.3M | $3.2B |
| UHS Dec | $262.0M | $524.7M | $1.1B | $849.2M |
| Peer median | $1.5B | $1.5B | $1.1B | $1.3B |
FCF margin, FY2022 to FY2025
Free cash flow / revenue.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | −1.0% | 1.8% | −0.6% | 3.1% |
| VTRS Dec | 15.9% | 16.4% | 13.4% | 13.5% |
| LH Dec | 12.9% | 7.2% | 8.4% | 8.6% |
| DVA Dec | 8.3% | 12.3% | 11.4% | 9.6% |
| HSIC Dec | 4.0% | 2.9% | 5.5% | 4.3% |
| REGN Dec | 36.3% | 29.5% | 25.8% | 28.4% |
| TEVA Dec | 7.0% | 5.3% | 4.5% | 6.7% |
| IQV Dec | 11.0% | 10.0% | 13.7% | 12.6% |
| VRTX Dec | 44.0% | 33.8% | −7.2% | 26.6% |
| UHS Dec | 2.0% | 3.7% | 7.1% | 4.9% |
| Peer median | 11.0% | 10.0% | 8.4% | 9.6% |
Return on equity, FY2022 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | −7.1% | −26.4% | −1.1% | 10.2% |
| VTRS Dec | 9.9% | 0.3% | −3.4% | −23.9% |
| LH Dec | 12.7% | 5.3% | 9.3% | 10.2% |
| DVA Dec | 78.7% | 65.5% | n/m | n/m |
| HSIC Dec | 15.6% | 11.4% | 11.5% | 12.3% |
| REGN Dec | 19.1% | 15.2% | 15.0% | 14.4% |
| TEVA Dec | −31.3% | −7.4% | −30.5% | 17.8% |
| IQV Dec | 18.9% | 22.2% | 22.6% | 20.9% |
| VRTX Dec | 23.9% | 20.6% | −3.3% | 21.2% |
| UHS Dec | 11.4% | 11.7% | 17.1% | 20.5% |
| Peer median | 15.6% | 11.7% | 10.4% | 16.1% |
Debt / equity, FY2022 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | - | 5.75 | 1.58 | 1.34 |
| VTRS Dec | 0.91 | 0.89 | 0.75 | 0.98 |
| LH Dec | 0.53 | 0.64 | 0.79 | 0.65 |
| DVA Dec | 12.53 | 7.95 | n/m | n/m |
| HSIC Dec | 0.33 | 0.64 | 0.75 | 0.96 |
| REGN Dec | 0.09 | 0.08 | 0.07 | 0.06 |
| TEVA Dec | 2.72 | 2.64 | 3.31 | 2.12 |
| IQV Dec | 2.21 | 2.24 | 2.30 | 2.42 |
| VRTX Dec | - | - | - | 0.00 |
| UHS Dec | 0.81 | 0.80 | 0.68 | 0.66 |
| Peer median | 0.86 | 0.84 | 0.75 | 0.81 |
EPS (diluted), FY2022 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| BTSG Dec | −$0.46 | −$1.31 | −$0.09 | $0.87 |
| VTRS Dec | $1.71 | $0.05 | −$0.53 | −$3.00 |
| LH Dec | $13.97 | $4.77 | $8.84 | $10.46 |
| DVA Dec | $5.85 | $7.42 | $10.73 | $9.84 |
| HSIC Dec | $3.91 | $3.16 | $3.05 | $3.27 |
| REGN Dec | $38.22 | $34.77 | $38.34 | $41.48 |
| TEVA Dec | −$2.20 | −$0.50 | −$1.45 | $1.21 |
| IQV Dec | $5.72 | $7.29 | $7.49 | $7.84 |
| VRTX Dec | $12.82 | $13.89 | −$2.08 | $15.32 |
| UHS Dec | $9.14 | $10.23 | $16.82 | $23.10 |
| Peer median | $5.85 | $7.29 | $7.49 | $9.84 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out BTSG and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: BTSG's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BTSG/export.csv") into a cell.